Request Call Back

Contact Us

Case Review Form
*    Denotes required field.

Describe accident or indicate name of drug or device

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Xarelto (Rivaroxaban) Blood Clot Side Effects May Lead to Personal Injury Lawsuits

Xarelto (Rivaroxaban), a Deep Vein Thrombosis Blood Thinner Drug, Relates to Blood Clot Side Effects and May Lead to Wrongful Death and Personal Injury Class Action Lawsuits

Xarelto blood clots, Xareto Side Effects Lawsuits

Xarelto blood clots, Xareto Side Effects Lawsuits

Our firm is investigating potential lawsuits on behalf of patients who suffered from Xarelto side effects. According to a report by the Institute for Safe Medication Practices (ISMP), Xarelto has been associated with “serious, disabling or fatal injury,” including blood clots or thromboembolic events.

Xarelto is used to prevent blood clots, deep vein thrombosis (DVT) and pulmonary embolism in patients who are undergoing knee or hip replacement surgery. Like Pradaxa, it is an alternative to warfarin (Coumadin), a much older anticoagulant.


ISMP QuarterWatch Report: Xarelto Linked to
Blood Clots and Pulmonary Embolism

The ISMP is a non-profit consumer safety group; several times a year, the organization issues a QuarterWatch report to update the public about the safety profile of suspect drugs. The report is based on data submitted to the U.S. Food and Drug Administration through the agency’s Adverse Event Reporting System (AERS).  In October 2012, ISMP issued a QuarterWatch report for adverse events reported to the FDA during first quarter of the year. The report focused on four drugs, including Xarelto, Tekturna, Actos and Cymbalta.

Xarelto was associated with the greatest number of adverse events for the first quarter of 2012 with 356 reports of
“serious, disabling or fatal injury”. The ISMP stated that “the largest group of rivaroxaban cases described the development of severe blood clots in younger patients (median age 66) taking the anticoagulant drug after hip or knee replacement surgery.” According to the report, blood clots the predominant adverse event reported to the FDA for first quarter of 2012, accounted for 158 cases.

Like warfarin, Xarelto is approved to prevent deep vein thrombosis in patients who have undergone knee or hip replacement surgery. Deep vein thrombosis is when a blood clot forms in the deep veins of the leg. If a part of this clot breaks off, it can be swept into the bloodstream and become lodged in the lungs; this is known as a pulmonary embolism and may be a life-threatening condition.

Legal Help for Victims of Xarelto Blood Clot Injuries

If you or a loved one took Xarelto and suffered from a blood clot, you may have valuable legal rights. To learn how our Xarelto drug injury lawyers can help you , please fill out our online form or call 1(800)YOURLAWYER (1-800-968-7529) today.  

Sources:

http://www.ismp.org/quarterwatch/pdfs/2012Q1.pdf


More on Eliquis

 

Pradaxa Bleeding Side Effects

Pradaxa Side Effects

Xarelto (Rivaroxaban) Blood Clot Side Effects May Lead to Personal Injury Lawsuits

Xarelto (Rivaroxaban)

 Pradaxa Bleeding Following Atrial Fibrillation Ablation

Pradaxa/Atrial Fibrillation

Pradaxa-Hemorrhaging

Pradaxa/Hemorrhaging



 

Xarelto (Rivaroxaban) Blood Clot Side Effects May Lead to Personal Injury LawsuitsRSS Feed

Bayer, J&J Faces New Xarelto Wrongful Death Lawsuit, Alleging Stroke

Dec 16, 2016
Litigation Continues to Mount over Xarelto Anticoagulant A new wrongful death lawsuit has been filed over the anticoagulant Xarelto against Janssen Pharmaceuticals, parent company Johnson & Johnson and Bayer Healthcare. The lawsuit was filed on behalf of a West Virginia man who died, allegedly due to Xarelto side effects. Bayer and Janssen are accused of failing to disclose the risks. The companies are faced with a number of lawsuits over bleeding-related injuries. Parker Waichman LLP...

Janssen Facing Suit due to Alleged Xarelto Complications

Dec 9, 2016
On September 1, 2016, a plaintiff filed a suit in St. Clair County Circuit Court against Janssen Research & Development, LLC, a subsidiary of Johnson & Johnson (J&J), creators of the anticoagulant, Xarelto. The lawsuit states that the plaintiff was not sufficiently warned regarding alleged risks and potential side effects in Janssen's promotion and marketing of Xarelto, reports the Madison-St. Clair Record. According to the lawsuit filed by the man, Janssen, despite being warned...

Blood Thinner Xarelto is Convenient but Controversial

Nov 30, 2016
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals, along with Bayer Corporation, manufactures the anticoagulant, Xarelto. Xarelto (rivaroxaban) is part of a new generation of drugs that is touted as more convenient, offering freedom from mandatory blood level monitoring and stringent dietary restrictions. However, with this convenience, patients have found there is a price to pay. That price is possible uncontrollable bleeding and other potentially life-threatening side...

More Lawsuits Added to Xarelto MDL, Litigation Moves Forward

Oct 10, 2016
Xarelto multidistrict litigation Against Janssen and Bayer Lawsuits continue to mount in the Xarelto multidistrict litigation (MDL) against Janssen, a Johnson & Johnson subsidiary, and Bayer AG. Plaintiffs in the MDL similarly allege that the anticoagulant Xarelto led to uncontrollable, sometimes fatal bleeding. The drug makers are accused of failing to disclose this risk to patients and their physicians. More than 7,000 lawsuits have been filed into the MDL in the Eastern District of...

BMJ Investigation Drug Makers Knew of Faulty Device During Xarelto Trials But Failed to Warn

Oct 6, 2016
BMJ Investigation Faild To Disclose Information in Clinical Trials A British Medical Journal (BMJ) investigation has found that the makers of Xarelto, an anticoagulant that has spurred a number of personal injury lawsuits, knew about safety concerns with a medical device used in Xarelto clinical trials but failed to disclose this information. The clinical trial in question is the ROCKET-AF, in which researchers compared adverse events in Xarelto users to warfarin users. A device used in...

More Xarelto (Rivaroxaban) Blood Clot Side Effects May Lead to Personal Injury Lawsuits News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo